In a paper published today in the journal Nature, a research team led by scientists at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR) and the University of São Paulo, demonstrates that two different ZIKV vaccine candidates provided complete protection in mice against a ZIKV strain from Brazil and suggest that a ZIKV vaccine for humans will likely be feasible.
Researchers from the Ragon Institute of Mass General, MIT, and Harvard and the Perelman School of Medicine at the University of Pennsylvania developed a new Dual CAR T cell immunotherapy that combats HIV infection in humanized mice.
Pregnant women show robust immune response to COVID vaccines, pass antibodies to newborns, in recent study published by Massachusetts General Hospital, Brigham and Women’s Hospital, and Ragon Institute researchers.
For all media inquiries, please contact our Communications team via ragoncommunications@partners.org. If you are a journalist interested in receiving our press releases, please put “Join Press Release List” in the subject line.
The Ragon Institute of Mass General, MIT, and Harvard brings together scientists and engineers from diverse fields to better understand the immune system and support human health.
The Administrative and Operations team manages the Ragon’s operations, administrative, and logistical functions.
Our collaborative ethos applies to every aspect of our Institute, and we are committed to being an engaged and involved member of the communities we are fortunate to be a part of.
